In summary, our observations indicate that LSD1 knockdown showed robust antitumor efficacy in the THP-1 xenograft tumor model, which is likely mediated through promoting myeloid differentiation and attenuating proliferation in vivo. The gene discussed is KDM1A; the disease is neoplasm.